REFERÊNCIAS VEPESID - INJETAVEL

             1. U.S. Public Health Service, National Institutes of Health: Recommendations for the Safe Handling of Parenteral Antineoplastic Drugs, 1983, NIH Publication No. 83-2621. For sale by the Superintendent of Documents, U.S. Government Printing Office, Washington, D.C. 20402.
           
            2. AMA Council on Scientific Affairs: Guidelines for Handling Parenteral Antineoplastics. JAMA, 253:1590-1592,1985.
           
            3. National Study Commission on Cytotoxic Exposure: Recommendations for Handling Cytotoxic Agents, 1987. Available from Louis P. Jeffrey, Sc.D., Chairman National Study Commission on Cytotoxic Exposure, Massachusetts College of Pharmacy and Allied Health Sciences, 179 Longwood Avenue, Boston, Massachusetts 0215.
           
            4. Clinical Oncological Society of Australia: Guidelines and Recommendations for Safe Handling of Antineoplastic Agents. Med J Aust, 1:426-428,1983.
           
            5. Jones, R.B. Frank, R. Mass, T. Safe Handling of Chemotherapeutic Agents: A Report from the Mount Sinai Medical Center. CA - A Cancer¹ Journal for Clinicians 33:258-263,1983.
           
            6. ASHP Technical Assistance Bulletin on Handling Cytotoxic and Hazardous Drugs. Am J Hosp Pharm,47:1033-1049,1990.
           
            7. OSHA Work-Practice Guidelines for Personnel Dealing with Cytotoxic (Antineoplastic) Drugs. Am J Hosp Pharm. 43:1193-1204,1980.
           

VENDA SOB PRESCRIÇÃO MÉDICA

USO RESTRITO A HOSPITAIS

* AMPOLA
** FRASCO-AMPOLA